Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...

Patients aren’t the only healthcare participants who believe self-care is necessary since the COVID-19 pandemic – 86.6% of healthcare professionals now believe so, too. However, connecting patients ...

About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

While much attention has been given to the novel science behind cell and gene therapies (CGTs), the success of every precision medicine starts and ends with the patient. The novel science behind CGTs ...

Greater transparency and independent evaluation are needed to understand the impact of the patient support programs that pharmaceutical companies offer for many expensive drugs, according to ...

Survey signals front-end therapy initiation is system-centric: only 20% report strong starts, with anxiety and limbo undermining engagement before first dose. Fragmented provider–payer–pharmacy ...

Four years ago, Barbara LaCoste began seeing blurry spots in her central line of vision. During an eye exam at the John A. Moran Eye Center, the 78-year-old received a diagnosis that was all too ...

The Patient Support Programs Canada conference is the premier event for professionals dedicated to advancing patient care and optimizing support programs across the Canadian healthcare landscape.

About 1 in 10 prescription drugs - mainly brand-name and expensive drugs and those for rare diseases - has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...